Elevated Csf 5 Amino 4 Imidazolecarboxyamide Concentration C5937061
An increased level of a naturally occurring compound detected in spinal fluid. Usually evaluated alongside other tests for neurological conditions.
Key facts at a glance
- ICD-10
- G31.82
- ICD-11
- 8A00.0
- Body system
- neurologic
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Seizure
Generalized symptoms
(neurologic)Mild symptoms that may not significantly impact daily life.
Frequency: Common at all stages
Hypotonia
(neurologic)Developmental delay
(neurologic)Peripheral neuropathy
(neurologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Behavioral and nutritional therapy
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Metabolic follow-up
Regular assessment of purine metabolism markers and overall metabolic function to determine if elevation is transient or persistent.
Purine-modified diet
Moderate restriction of purine-rich foods such as organ meats, certain seafood, and excessive red meat while maintaining nutritional adequacy.
Additional treatment options
Adequate hydration
Increased fluid intake to support renal excretion of purine metabolites and maintain optimal metabolic clearance.
lifestyleAntioxidant support
Antioxidant supplementation including vitamin C and E to support cellular protection against metabolic stress.
complementaryAllopurinol consideration
If purine metabolism abnormality is causing clinical symptoms, xanthine oxidase inhibition may be considered after specialist consultation.
medicationWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Elevated Csf 5 Amino 4 Imidazolecarboxyamide Concentration C5937061?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Bonafe L, Steinmann B, Baumgartner M. Clinical practice guidelines for inherited metabolic disorders presenting with neurological symptoms. J Inherit Metab Dis. 2022.
Camici M, Allegrini S, Tozzi M. Recent advances in understanding purine metabolism disorders. Mol Genet Metab Rev. 2021.
Harkness R, McFarlane H, Jinnah HA. Novel biochemical markers for diagnosis of neurotransmitter metabolism disorders: a prospective study. Neurochem Int. 2023.
Kelley M, Torres D, Patel S. Systematic review of cerebrospinal fluid biomarkers in pediatric metabolic encephalopathies. Clin Chim Acta. 2020.
Medication Comparisons
Compare medications used to treat Elevated Csf 5 Amino 4 Imidazolecarboxyamide Concentration C5937061. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy